HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis
Alexius Ramcharan, Karlijn J. van Stralen, Jaapjan D. Snoep, Aukje K. Mantel‐Teeuwisse, Frits R. Rosendaal, Carine J.M. Doggen (2008). HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis. Journal of Thrombosis and Haemostasis, 7(4), pp. 514-520, DOI: 10.1111/j.1538-7836.2008.03235.x.
